FARICIMAB for Choroidal neovascularisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 8 adverse event reports in the FDA FAERS database where FARICIMAB was used for Choroidal neovascularisation.

Most Reported Side Effects for FARICIMAB

Side Effect	Reports	%	Deaths	Hosp.
Off label use	32	8.4%	0	3
Uveitis	31	8.1%	0	0
No adverse event	27	7.1%	0	0
Drug ineffective	22	5.8%	0	1
Eye inflammation	18	4.7%	0	0
Cataract	16	4.2%	0	4
Death	16	4.2%	16	0
Vitritis	16	4.2%	0	0
Retinal haemorrhage	15	3.9%	0	3
Blindness	14	3.7%	0	0
Neovascular age-related macular degeneration	14	3.7%	0	1
Diabetic retinopathy	13	3.4%	0	1
Visual acuity reduced	13	3.4%	0	0
Iridocyclitis	12	3.2%	0	2
Cerebrovascular accident	10	2.6%	0	6